Literature DB >> 27544027

HLA-DR antigen-positive acute promyelocytic leukemia.

Alejandro S Mendoza1, Xin Qing2, Maria Dungo3, Joseph Lasky4, Eduard Panosyan4, Junchao Cai5.   

Abstract

Acute promyelocytic leukemia (APL) with t(15;17)(q22;q21)/PML-RARα is a subtype of acute myeloid leukemia (AML) with distinct morphologic and immunophenotypic characteristics. It is a highly aggressive disease that requires rapid diagnosis and early intervention. In addition to morphologic evaluation, flow cytometry has been widely used to facilitate prompt diagnosis of this disease. Compared with other types of AML, APL typically displays a triad of absent or weak CD34, absent HLA-DR, and positive CD117. HLA-DR positive APL is extremely rare and its clinical and pathological features have not been reported. A total of 45 cases of APL with t(15,17)/PML-RARα were diagnosed at Harbor-UCLA Medical Center from year 2006 to 2015. Among them, only two cases were positive for HLA-DR by flow cytometry immunophenotyping. Here we describe the clinical, morphologic, immunophenotypic, and cytogenetic features of these two cases. Published by Elsevier Inc.

Entities:  

Keywords:  Acute promyelocytic leukemia; Flow cytometry; HLA-DR; Prognosis

Mesh:

Substances:

Year:  2016        PMID: 27544027     DOI: 10.1016/j.yexmp.2016.07.013

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  1 in total

1.  Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

Authors:  Yomna M El-Meligui; Heba E Abd Elrhman; Ahmad Salahuddin; Manal Ali Hamouda; Amira B Kassem
Journal:  Pharmgenomics Pers Med       Date:  2021-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.